A Dose-Finding Study of Pertuzumab (Perjeta) in Combination With Trastuzumab (Herceptin) in Healthy Male Participants and Women With Early Breast Cancer (EBC)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Early Breast Cancer
Interventions: DRUG: Trastuzumab|DRUG: Pertuzumab
Sponsor: Hoffmann-La Roche